Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Media Coverage of First-in-Human Trial Results of Bashir Endovascular Catheter

View All News

Riyaz Bashir, MD, FACC, RVT, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital, along with Nicholas Green, Director of Research & Development at Thrombolex, Inc., developed two catheters that received U.S. Food and Drug Administration premarket notification clearance last year. Now, the results of a first-in-human trial confirm early safety and feasibility of the Bashir Endovascular Catheter for pharmacomechanical catheter-directed thrombolysis in patients with acute pulmonary embolism. Endovascular Today, Venous News and TCTMD covered the announcement.